AFFLUENT MEDICAL |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.76 EUR | +1.15% |
|
-4.61% | -4.61% |
| Apr. 25 | Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 13 | AFFLUENT MEDICAL : Invest Securities reiterates its opinion | CF |
| Sales 2023 * | - | Sales 2024 * | - | Capitalization | 58.26M 54.32M |
|---|---|---|---|---|---|
| Net income 2023 * | -17M -15.85M | Net income 2024 * | -20M -18.65M | EV / Sales 2023 * | - |
| Net Debt 2023 * | 10.73M 10M | Net Debt 2024 * | 21.15M 19.72M | EV / Sales 2024 * | - |
| P/E ratio 2023 * |
-3.12
x | P/E ratio 2024 * |
-3.32
x | Employees | 52 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 29.65% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +1.15% | ||
| 1 week | -4.61% | ||
| Current month | +0.86% | ||
| 1 month | +2.92% | ||
| 3 months | +6.67% | ||
| 6 months | +65.26% | ||
| Current year | -4.61% |
1 week
1.74
1.92
1 month
1.712.06
Current year
1.232.13
1 year
0.932.30
3 years
0.938.60
5 years
0.938.60
10 years
0.938.60
| Managers | Title | Age | Since |
|---|---|---|---|
Sébastien Ladet
CEO | Chief Executive Officer | - | 22-08-21 |
Luc Parisot
DFI | Director of Finance/CFO | - | - |
Benjamin Renault
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 65 | 18-03-26 | |
| Director/Board Member | - | 18-03-26 | |
| Director/Board Member | - | 22-01-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 1.76 | +1.15% | 767 |
| 24-04-24 | 1.74 | -1.14% | 2,150 |
| 24-04-23 | 1.76 | -2.22% | 3,889 |
| 24-04-22 | 1.8 | -4.26% | 8,371 |
| 24-04-19 | 1.88 | +1.90% | 5,043 |
Real-time Euronext Paris, April 25, 2024 at 11:29 am EDT
More quotes
Affluent Medical is specialized in the development and production of mini-invasive prostheses used for treating heart disease and urinary incontinence.
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.76
EUR
Average target price
3.367
EUR
Spread / Average Target
+91.29%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.61% | 58.26M | |
| +72.64% | 12.34B | |
| -18.30% | 7.96B | |
| +15.38% | 7.16B | |
| +2.18% | 5.72B | |
| +6.51% | 5.03B | |
| +21.99% | 4.35B | |
| -21.72% | 3.99B | |
| -41.36% | 2.21B | |
| +0.87% | 2.01B |
- Stock Market
- Equities
- AFME Stock
